Zobrazeno 1 - 10
of 199
pro vyhledávání: '"A. A. Stomakhin"'
We present a novel hybrid incompressible flow/material point method solver for simulating the combustion of flammable solids. Our approach utilizes a sparse grid representation of solid materials in the material point method portion of the solver and
Externí odkaz:
http://arxiv.org/abs/2408.07276
Autor:
Viktoriya E. Kuznetsova, Valeriy E. Shershov, Georgiy F. Shtylev, Ivan Yu. Shishkin, Veronika I. Butvilovskaya, Andrey A. Stomakhin, Irina V. Grechishnikova, Olga A. Zasedateleva, Alexander V. Chudinov
Publikováno v:
Molecules, Vol 29, Iss 19, p 4747 (2024)
A general approach is presented for synthesizing alkyne-modified nucleoside triphosphates via the Sonogashira cross-coupling reaction of unprotected halogenated 2ʹ-deoxynucleoside, followed by monophosphorylation and the reaction of the correspondin
Externí odkaz:
https://doaj.org/article/c0e125fdd8cf492f804da5138bec3fd4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kuznetsova, Viktoriya E., Shershov, Valeriy E., Shtylev, Georgiy F., Shishkin, Ivan Yu., Butvilovskaya, Veronika I., Stomakhin, Andrey A., Grechishnikova, Irina V., Zasedateleva, Olga A., Chudinov, Alexander V.
Publikováno v:
Molecules; Oct2024, Vol. 29 Issue 19, p4747, 12p
Autor:
Ksenia Glumakova, Georgy Ivanov, Valeria Vedernikova, Lena Shyrokova, Timofey Lebedev, Andrei Stomakhin, Anastasia Zenchenko, Vladimir Oslovsky, Mikhail Drenichev, Vladimir Prassolov, Pavel Spirin
Publikováno v:
Pharmaceutics, Vol 15, Iss 10, p 2389 (2023)
Nucleoside reverse transcriptase inhibitors are the first class of drugs to be approved by the FDA for the suppression of HIV-1 and are widely used for this purpose in combination with drugs of other classes. Despite the progress in HIV-1 treatment,
Externí odkaz:
https://doaj.org/article/2cf569d42942437cac2abc623ad8e506
Autor:
Kolganova, Natalia A.1 (AUTHOR), Tsvetkov, Vladimir B.2,3,4 (AUTHOR), Stomakhin, Andrey A.1 (AUTHOR), Surzhikov, Sergei A.1 (AUTHOR), Timofeev, Edward N.1 (AUTHOR) edward@eimb.ru, Varizhuk, Irina V.1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. May2023, Vol. 24 Issue 9, p8406. 13p.
Autor:
Natalia A. Kolganova, Vladimir B. Tsvetkov, Andrey A. Stomakhin, Sergei A. Surzhikov, Edward N. Timofeev, Irina V. Varizhuk
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 9, p 8406 (2023)
Modification of DNA aptamers is aimed at increasing their thermodynamic stability, and improving affinity and resistance to biodegradation. G-quadruplex DNA aptamers are a family of affinity ligands that form non-canonical DNA assemblies based on a G
Externí odkaz:
https://doaj.org/article/90a5a226a0e0449da3c85fcb5f1daa75
Autor:
Irina V. Varizhuk, Vladimir B. Tsvetkov, Ilya Yu. Toropygin, Andrey A. Stomakhin, Natalia A. Kolganova, Sergei A. Surzhikov, Edward N. Timofeev
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 604 (2023)
Currently, oligonucleotide therapy has emerged as a new paradigm in the treatment of human diseases. In many cases, however, therapeutic oligonucleotides cannot be used directly without modification. Chemical modification or the conjugation of therap
Externí odkaz:
https://doaj.org/article/241ae08ee1a54381983f51819adada1b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vladimir B. Tsvetkov, Irina V. Varizhuk, Nikolay N. Kurochkin, Sergei A. Surzhikov, Igor P. Smirnov, Andrey A. Stomakhin, Natalia A. Kolganova, Edward N. Timofeev
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 7, p 3820 (2022)
Oligonucleotide–peptide conjugates (OPCs) are a promising class of biologically active compounds with proven potential for improving nucleic acid therapeutics. OPCs are commonly recognized as an efficient instrument to enhance the cellular delivery
Externí odkaz:
https://doaj.org/article/8a6f2607147a4ee49c452c3fc4d206ae